Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision from v3.5.2 to v3.5.3 indicates a small update to the page version. There is no visible change to the study details or content shown in the provided data.SummaryDifference0.0%

- Check16 days agoChange DetectedUpdated the displayed collaborator name formatting from **“Ono Pharmaceutical Co. Ltd”** to **“Ono Pharmaceutical Co., Ltd.”**SummaryDifference0.0%

- Check23 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2; no substantive changes to the study details or navigation are evident.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision: v3.5.0 was added; 'Sjogren's Syndrome' resources were removed and the prior Revision: v3.4.3 marker was deleted.SummaryDifference0.1%

- Check59 days agoChange DetectedA new site revision entry v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

- Check87 days agoChange DetectedA minor site revision (v3.4.2) was added; the non-critical funding-status notice and a prior revision notice (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.